Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Nissei Capital
investment firm
About
Nissei Capital, a Japanese investment company, offers early- and later-stage venture investment services and solutions.
- Tokyo,Tokyo,Japan
Highlights
Details
- Founded date
- Jan 1, 1991
- Operating Status
- Active
- Investor Type
- Venture Capital
Investments
Number of Investments
Number of Lead Investments
14
4
Nissei Capital has made 14 investments. Their most recent investment was on
Sep 22, 2021, when Wevnal raised ¥600M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 22, 2021
Wevnal
|
Series A | ¥600M | Advertising | — |
|
Aug 18, 2021
Sprocket
|
Series C | ¥760M | Customer Service | — |
|
Aug 10, 2021
Smart119
|
Series B | ¥306.75M | Artificial Intelligence | Yes |
|
Jan 23, 2020
minma
|
Series A | $282.15M | E-Commerce | — |
|
Aug 23, 2019
Smart119
|
Series A | ¥91M | Artificial Intelligence | Yes |
Exits
Nissei Capital has had 4 exits. Nissei Capital most notable exits include Kringle Pharma , HENNGE
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Dec 28, 2020 | Kringle Pharma | IPO | Biotechnology | Detail |
| Oct 8, 2019 | HENNGE | IPO | Information Technology | Detail |
| Jun 26, 2019 | crea-japan | M&A | Information Technology | Detail |
| Mar 16, 2010 | CellSeed | IPO | Alternative Medicine | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
